Benabente, Helfseth P.

HRN: 28-96-96  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/13/2026
05/20/2026
IV
500mg
Q 8 Hours
Hepatobiliary Pathology
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines